Jinhua Song

机构：Shandong Tumor Hospital, Jiangsu Province Hospital, Shandong First Medical University, Nanjing Medical University

发表论文 9 篇 · 总被引 325 次 · h-index 6

代表论文

• Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial (2022 · Journal for ImmunoTherapy of Cancer · 被引 218)
• Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma (2022 · Acta Biomaterialia · 被引 36)
• Exosome-transmitted circ_002136 promotes hepatocellular carcinoma progression by miR-19a-3p/RAB1A pathway (2022 · BMC Cancer · 被引 29)
• GJB2 Promotes HCC Progression by Activating Glycolysis Through Cytoplasmic Translocation and Generating a Suppressive Tumor Microenvironment Based on Single Cell RNA Sequencing (2024 · Advanced Science · 被引 24)
• Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma (2022 · Cancer Cell International · 被引 9)
• A 3D multi-modal intelligent intervention system using electromagnetic navigation for real-time positioning and ultrasound images: a prospective randomized controlled trial (2022 · Annals of Translational Medicine · 被引 9)